000 01367 a2200421 4500
005 20250515234732.0
264 0 _c20101230
008 201012s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2010.08.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaylor, Paul H
245 0 0 _aIRX-2 increases the T cell-specific immune response to protein/peptide vaccines.
_h[electronic resource]
260 _bVaccine
_cOct 2010
300 _a7054-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3T3 Cells
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCytokines
_ximmunology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aProstate-Specific Antigen
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aVaccines, Subunit
_ximmunology
700 1 _aHernandez, Karla E
700 1 _aNixon, April E
700 1 _aBrandwein, Harvey J
700 1 _aHaas, Gabriel P
700 1 _aWang, Ching Y
700 1 _aHadden, John W
773 0 _tVaccine
_gvol. 28
_gno. 43
_gp. 7054-62
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2010.08.014
_zAvailable from publisher's website
999 _c20046280
_d20046280